title: When would I use medical therapies for the treatment of primary hyperparathyroidism?
abstract: Although there may be controversy surrounding the indications for parathyroidectomy in primary hyperparathyroidism, it remains the only accepted definitive therapy. However, even if parathyroidectomy is indicated, some patients refuse surgery, are medically unfit or have residual or recurrent disease inaccessible to further surgery. Some of these patients may be suitable for long-term observation but others require intervention for management of symptomatic or moderate to severe hypercalcaemia, loss of bone mineral density or renal calculi. The selection of a suitable therapy for each patient should be individualized.
authors.affiliation: Department of Endocrinology, University Hospital Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.
authors.forename: Rachel K
authors.initials: RK
authors.lastname: Crowley
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Gittoes
mesh_terms: D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D057966:Calcimimetic Agents / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000628:therapy; D049950:Hyperparathyroidism, Primary / Q000601:surgery / Q000628:therapy*; D007669:Kidney Calculi / Q000517:prevention & control / Q000628:therapy; D008297:Male; D010024:Osteoporosis / Q000517:prevention & control / Q000628:therapy; D016105:Parathyroidectomy; D057285:Precision Medicine
chemical_list: D050071:Bone Density Conservation Agents; D057966:Calcimimetic Agents; D002118:Calcium